v3.26.1
Accrued Expenses and Other Current Liabilities
6 Months Ended
Jun. 30, 2026
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities

Note 6. Accrued Expenses and Other Current Liabilities

 

Accrued expenses and other current liabilities consisted of the following (in thousands):

 

 

June 30,
2026

 

 

December 31,
2025

 

Accrued compensation and benefits

 

$

4,773

 

 

$

8,767

 

Accrued professional services

 

 

9,161

 

 

 

9,195

 

Excise and franchise taxes payable

 

 

11,304

 

 

 

10,054

 

Collateralized borrowings

 

 

2,413

 

 

 

2,264

 

Software license fee payable

 

 

9,538

 

 

 

9,547

 

Accrued Monarch legal settlement

 

 

1,314

 

 

 

1,314

 

Accrued major maintenance

 

 

295

 

 

 

3,669

 

Interest and commitment fee payable

 

 

145

 

 

 

140

 

Other accrued liabilities

 

 

3,018

 

 

 

2,752

 

Total accrued expenses and other current liabilities

 

$

41,961

 

 

$

47,702

 

Collateralized Borrowings

The Company has a revolving accounts receivable financing arrangement that allows the Company to borrow a designated percentage of eligible accounts receivable, as defined in the agreement, up to a maximum unsettled amount of $5.0 million. The agreement is secured by a first security interest in certain assets of Southern Airways Express. The related interest rate is the prime rate plus 1% per annum. Additionally, the Company pays certain ancillary fees associated with each borrowing that vary depending on the borrowed amount and duration, which is generally no more than 45 days.

For the three months ended June 30, 2026, the Company borrowed a total of $7.9 million under this financing facility, of which $5.5 million was settled through the transfer of pledged receivables. Interest expense incurred on these borrowings for the three months

ended June 30, 2026 amounted to $101 thousand, and is included in interest expense in the accompanying Condensed Consolidated Statements of Operations.

 

For the six months ended June 30, 2026, the Company borrowed a total of $14.4 million under this financing facility, of which $12.0 million was settled through the transfer of pledged receivables. Interest expense incurred on these borrowings for the six months ended June 30, 2026 amounted to $177 thousand, and is included in interest expense in the accompanying Condensed Consolidated Statements of Operations.

As of June 30, 2026 the Company was in compliance with all covenants.

Accrued Compensation and Benefits

The Company maintains incentive compensation programs under which payouts are based on a combination of performance metrics and are subject to discretionary adjustments by the Company’s board of directors (the “Board”).

As of December 31, 2025, the Company recorded an accrual of $4.8 million representing its estimate of expected payouts under the programs. During the six months ended June 30, 2026, final payouts under the plans were approved at $1.8 million. The resulting $3.0 million reduction in accrued compensation has been recognized as a $0.3 million reduction to sales and marketing expense and a $2.7 million reduction to general and administrative expenses in the accompanying Condensed Consolidated Statements of Operations. The resulting $1.8 million accrual was paid during the three months ended June 30, 2026. Additionally, the Company accrued $2.5 million applicable to the 2026 incentive compensation program during the three months ended June 30, 2026.

 

Accrued Professional Services

During the fourth quarter of 2024, the Company entered into agreements with several professional service firms engaged in support of the Company’s July 27, 2023 direct listing on the NYSE. These agreements modify the payment terms of prior service agreements to be contingent on future equity or debt financing by the Company. The Company originally estimated that a total of $7.1 million would be due under these agreements over a five year period. Given the uncertainty regarding the timing and amount of payment, all amounts have been classified as current liabilities within the Company’s Condensed Consolidated Balance Sheets. During the year ended December 31, 2025, and the six months ended June 30, 2026, the Company has continued to make contractual payments against certain of these liabilities, with $6.7 million remaining as a current liability within the Company’s Condensed Consolidated Balance Sheets as of June 30, 2026.